Author: Dr Anika Schröter
The development of RNA-based drugs has increased within the past years and is a promising field of research in the pharmaceutical industry. It is transforming the industry and will offer new hope for patients with unmet medical needs.
RNA-based drugs have several advantages over conventional drugs, such as the ability to target previously undruggable pathways, the rapid and cost-effective development, and the potential for personalized medicine. However, RNA-based drugs also face some challenges, such as the stability, delivery, and safety of the RNA molecules.
This whitepaper informs about the challenges with the 'standard' non-clinical program for different RNA-based drugs, focusing on safety evaluation.
Download now the white paper 'Non-clinical aspects of RNA-based drug development'.
We hope you enjoy reading it!
Our global and local experts will update you every two months with the latest regulatory and legislative developments. Thus, you will always have the essential information and trends in regulatory affairs at your fingertips!
Familiarize yourself with and explore the basic regulatory requirements and certification audit guidelines for auditing EU agricultural funds expenditures in the 2023-2027 programming period.
This topical in-person conference is about the latest developments in artificial intelligence and intellectual property. Attendees will get insights into the 'hot' topics of this super trend from top speakers from the industry and private practice.
The online seminar provides you with a comprehensive insight into both the legal and regulatory obligations for the prevention and combating of money laundering.
We will focus on how to integrate compliance and governance into Medical Affairs activities and ensure quality documentation that is both effective and pragmatic.
This course offers a deep dive into patient involvement in HTA processes across Europe, with a focus on the UK and Germany - learn practical approaches, regulatory insights, and how to engage meaningfully with patient organisations.
This live webcast provides in-depth guidance on effectively protecting your patent in the U.S. It offers a comprehensive overview of the formal requirements for U.S. patent prosecution, ensuring compliance and minimizing procedural risks.
This live webcast course deals with detailed guidance to the formal requirements of the PCT and information on the regulations related to the PCT.
Explore how recent U.S. pharmaceutical pricing reforms may impact the European pharma sector. This online seminar provides a transatlantic perspective on policy trends, trade risks, and pricing dynamics.
Regulatory expectations regarding risk management for pharmaceuticals in (emerging) markets often contend with the stringent standards set by the EU/ICH regions. Join us in five consecutive webcasts to gain insights into local pharmacovigilance systems in different countries and regions, and learn how to integrate them into your global PV system while maintaining a clear overview!
Our experienced speakers will help you prepare for all the challenges facing board members in German banks.
